Home / Advocate / Letters and Statements

Letters and Statements

ACCC writes and signs on to letters to Congress and the Administration to promote our policy interests. We also write advocacy statements, blog posts, and opinion pieces on a wide range of topics in cancer care. Questions related to health policy? Contact Nicole Tapay, JD, Director, Cancer Care Delivery & Health or Meagan O’Neill, MS, Executive Director of ACCC.

Follow ACCC (@ACCCBuzz) on Twitter for late-breaking cancer policy news and announcements.

Latest Letters

ACCC Expresses Concern to FDA Regarding Inspection Delays
October 11, 2022

In a letter to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., ACCC raises concern about recent delays in inspections of manufacturing facility that have led to interruptions in the approval of breakthrough therapies. We are particularly concerned when these delays impact novel treatments for diseases without FDA-approved therapies available and those that disproportionately impact minority communities.
Read the Letter

1 2

Advocacy News Releases

ACCC Celebrates Reintroduction of Policy That Will Bring Early Cancer Detection Tools to Cancer Centers Across the Country

Feb 06, 2025
Association of Cancer Care Centers (ACCC) Announces Special Grant to Firefighter Support Network

Jan 13, 2025

ROCKVILLE - The Association of Cancer Care Centers (ACCC) Board of Trustees today released the following statement regarding the firefighters currently battling wildfires in Los Angeles County:
ACCC Statement in Support of Bipartisan Year-End Legislation

Dec 18, 2024

The Association of Cancer Care Centers (ACCC) released the following statement in support of the bipartisan legislative package to be considered this week, including the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407) / the Medicare Multi-Cancer Early Detection Screening Coverage Act (S. 2085) to create a meaningful pathway for seniors to have access to the newest transformational tools in cancer detection.
ACCC Statement on Chemotherapy Drug Shortages

Jun 14, 2023

The Association of Community Cancer Centers (ACCC) is highly concerned about the ongoing shortages of platinum-based chemotherapy agents (e.g., cisplatin and carboplatin), two medications that (individually or in combination) treat and cure a wide range of cancers, including but not limited to gastric, pancreatic, colorectal, esophageal, cervical, and ovarian.

Read All News Releases

Share

In This Section

Letters and Statements

Latest Letters

Advocacy News Releases